Search results for "Cancer survival"
Docetaxel may prolong prostate cancer survival in patients with metastasis
Docetaxel added to the start of hormone therapy for metastatic prostate cancer may prolong survival compared to patients who received hormone therapy alone, according to early results from a trial.
https://immattersacp.org/weekly/archives/2013/12/17/4.htm
17 Dec 2013
Transitional care management services change in 2013
Learn how to recoup the increased reimbursement offered in the 2013 Medicare Physician Fee Schedule by using two new codes and modifications.
https://immattersacp.org/archives/2013/01/coding.htm
1 Jan 2013
Study compares after-effects of prostatectomy, active surveillance, radiation, hormone therapy for prostate cancer
Estimates of long-term bowel, bladder, and sexual function after localized prostate cancer treatment may enable men to make informed choices about care, the authors said.
https://immattersacp.org/weekly/archives/2020/01/28/4.htm
28 Jan 2020
Internist follow-up key for breast cancer survivors
Breast cancer survivors may recover from their illness only to face the same diseases as their “well” peers, such as hypertension and diabetes. Experts suggest a shared care model to keep breast cancer survivors healthy.
https://immattersacp.org/archives/2009/05/breast.htm
1 May 2009
Childhood cancer survivors develop many chronic conditions
Adult survivors of childhood cancer have an extraordinarily high rate of chronic health problems, a recent study found.
https://immattersacp.org/weekly/archives/2013/06/18/7.htm
18 Jun 2013
Patients and priorities in prostate cancer care
Prostate cancer requires men to work through a multitude of treatment options, and if the patient ends up settling on active surveillance, then the internist's role is even more important moving forward.
https://immattersacp.org/archives/2017/11/patients-and-priorities-in-prostate-cancer-care.htm
1 Nov 2017
ASCO guideline update changes tamoxifen recommendations
The American Society of Clinical Oncology (ASCO) recently released an updated guideline that increased the recommended length of tamoxifen therapy in women with hormone receptor-positive breast cancer.
https://immattersacp.org/weekly/archives/2014/06/03/2.htm
3 Jun 2014